Article Text

Download PDFPDF
Haemorrhagic cholecystitis: a rare entity not to be forgotten
  1. Zi Qin Ng1,2,
  2. Sharin Pradhan2,
  3. Kim Cheah3,
  4. Ruwan Wijesuriya2
  1. 1Royal Perth Hospital, Perth, Australia
  2. 2Department of General Surgery, St John of God Midland Public and Private Hospitals, Midland, Western Australia, Australia
  3. 3Australian Clinical Labs, St John of God Midland Public and Private Hospitals, Midland, Western Australia, Australia
  1. Correspondence to Dr Zi Qin Ng, kentng{at}


Haemorrhagic cholecystitis is a rare entity of acute cholecystitis that carries a high morbidity and mortality rate if management is delayed. Its clinical course can mirror that of acute cholecystitis. Characteristic findings on ultrasound or CT scan are useful clues to early diagnosis. Urgent cholecystectomy is required prior to progressing to perforation of gallbladder. Most of the literature are case reports with causes associated with anticoagulation. Herein, we described a morbidly obese patient with poorly controlled diabetes presenting with non-specific right upper quadrant pain and was subsequently diagnosed with haemorrhagic cholecystitis. A review of the literature was also performed to summarise the potential clinical presentations, distinctive imaging findings and management options available for this rare condition.

  • general surgery
  • surgery
  • biliary intervention

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors ZQN designed the study, collected the data and drafted the article. KC prepared the histopathology slides. RW co-designed the study and supervised the study. SP, KC and RW critically reviewed the article. All authors analysed the data and approved the final version of the article to be published.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.